本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

IGM Biosciences

1.27
-0.0100-0.78%
盘后1.26-0.0067-0.53%16:52 EDT
成交量:10.88万
成交额:13.88万
市值:7,644.02万
市盈率:-0.39
高:1.29
开:1.29
低:1.27
收:1.28
数据加载中...
2023/12/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/08

重要事件披露

Form 8-K - Current report
2023/11/16

SEC问询函

Form CORRESP - Correspondence
2023/11/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/13

重要事件披露

Form 8-K - Current report
2023/10/04

重要事件披露

Form 8-K - Current report
2023/10/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/04

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/03

重要事件披露

Form 8-K - Current report
2023/07/20

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/06/29

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/06/28

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/06/27

重要事件披露

Form 8-K - Current report
2023/06/23

重要事件披露

Form 8-K - Current report
2023/06/22

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2023/06/22

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2023/06/21

重要事件披露

Form 8-K - Current report
2023/06/14

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]